Return to search

MaaT Pharma fetches Series B

MaaT Pharma, a French clinical-stage oncology company, has secured 18 million euros in Series B financing.

MaaT Pharma, a French clinical-stage oncology company, has secured 18 million euros in Series B financing. The investors were SymBiosis, Seventure Partners, Crédit Mutuel Innovation, and Biocodex.

Source: Press Release